Successful treatment of Leuconostoc bacteremia in a neutropenic patient with tigecycline (original) (raw)

Leuconostoc species as a cause of bacteremia: Two case reports and a literature review

European Journal of Clinical Microbiology & Infectious Diseases, 1991

Tigecycline use in serious nosocomial infections: a drug use evaluation

BMC infectious diseases, 2010

Safety and Efficacy of Intravenous Tigecycline in Subjects with Secondary Bacteremia: Pooled Results from 8 Phase III Clinical Trials

Abel Jasovich

Clinical Infectious Diseases, 2010

View PDFchevron_right

Derya Aysev

Journal of Pediatric Research, 2017

View PDFchevron_right

Breakthrough bacteraemia with a susceptible Enterococcus faecalis during tigecycline monotherapy

Aji Balaji

Journal of …, 2010

View PDFchevron_right

A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms …

Krasimir Vasilev

Journal of …, 2008

View PDFchevron_right

Impact of β-lactam + Aminoglycoside Combination Regimen As Empirical Therapy For the Treatment of Bacteraemia Due to Gram-Negative Bacilli in Neutropenic Haematological Patients In An Era Of Antimicrobial Resistance (AMINOLACTAM Study)

Marta Ulldemolins

Biomedical Journal of Scientific & Technical Research, 2018

View PDFchevron_right

A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae

Miguel Sanchez

Journal of Antimicrobial Chemotherapy, 2008

View PDFchevron_right

Clinical experience with tigecycline as treatment for serious infections in elderly and critically ill patients

Chang-phone Fung, Fu-der Wang

Journal of Microbiology, Immunology and Infection, 2011

View PDFchevron_right

Successful tigecycline lock therapy in a Lactobacillus rhamnosus catheter-related bloodstream infection

Roberta Mannino

Infection, 2011

View PDFchevron_right

Use of Tigecycline in Pediatric Patients With Infections Predominantly Due to Extensively Drug-Resistant Gram-Negative Bacteria

Elias Iosifidis

Journal of the Pediatric Infectious Diseases Society, 2016

View PDFchevron_right

Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report

Despoina Koulenti

Journal of Antimicrobial Chemotherapy, 2006

View PDFchevron_right

Tigecycline in the treatment of infections from multi-drug resistant gram-negative pathogens

Maria Kompoti, Garyphallia Poulakou, Apostolos Armaganidis

Journal of Infection, 2009

View PDFchevron_right

Clinical and Microbiological Outcomes of Serious Infections with Multidrug-Resistant Gram-Negative Organisms Treated with Tigecycline

Darren Linkin

Clinical Infectious Diseases, 2008

View PDFchevron_right

Tigecycline Treatment of Critically Ill Patients: The Latinuser Experience

Sebastián Ugarte Ubiergo

Current Clinical Pharmacology, 2011

View PDFchevron_right

High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria

Teresa Spanu

Critical Care, 2014

View PDFchevron_right

Teicoplanin in the treatment of Gram-positive bacteraemia in neutropenic patients

Alessandro Venditti

British Journal of Haematology, 1990

View PDFchevron_right

Clinical efficacy of tigecycline used as monotherapy or in combination regimens for complicated infections with documented involvement of multiresistant bacteria

Wolfgang Heizmann

Infection, 2015

View PDFchevron_right

Changes in the Etiology of Bacteremia in Febrile Neutropenic Patients and the Susceptibilities of the Currently Isolated Pathogens

Reuben Ramphal

Clinical Infectious Diseases, 2004

View PDFchevron_right

Bacteraemia caused by Leptotrichia trevisanii in a neutropenic patient

Jan Verhaegen

Anaerobe, 2011

View PDFchevron_right

Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin

Arnold Lentnek

Diagnostic Microbiology and Infectious Disease, 2009

View PDFchevron_right

The Experience of a Novel Glycylcycline Antibiotic for a Patient with Infection Caused by Multiple Drug-Resistant Pathogens: What is the Benefit?

Chung-Lieh Hung

International Journal of Gerontology, 2008

View PDFchevron_right

Efficacy of Tigecycline as Salvage Therapy in Multidrug-Resistant Febrile Neutropenia in Patients with Acute Leukemia—A Single Center Analysis

Walter Fiedler

Antibiotics, 2022

View PDFchevron_right

Tigecycline is efficacious in the treatment of complicated intra-abdominal infections

Mircea Beuran

2005

View PDFchevron_right

Tigecycline Treatment of Urinary Tract Infection and Prostatitis: Case Report and Literature Review

Duane Bates

The Canadian Journal of Hospital Pharmacy, 2012

View PDFchevron_right

Outcomes in patients infected with carbapenem-resistant Acinetobacter baumannii and treated with tigecycline alone or in combination therapy

Merve Taşyaran

Infection, 2011

View PDFchevron_right

How to treat severe infections in critically ill neutropenic patients?

Elie Azoulay

BMC Infectious Diseases, 2014

View PDFchevron_right

Multiresistant gram-negative rods causing bacteriemia in neutropenic patient: 10 years experience at a public hospital of buenos aires province

FACUNDO ARGUELLO

International Journal of Infectious Diseases, 2018

View PDFchevron_right

Efficacy of intravenous tigecycline in patients with Acinetobacter complex infections: results from 14 Phase III and Phase IV clinical trials

Alvaro Quintana

Infection and Drug Resistance, 2017

View PDFchevron_right

Successful treatment of Leuconostoc bacteremia in a neutropenic patient with tigecycline (original) (raw)

Related papers